Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1

Conditions

Warts 1High-grade Anal Intraepithelial Neoplasia 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × green tea extract polyphenone E × Clear all
NCT04055142 2024-07-10

TreatAIN

Hospital Universitari Vall d'Hebron Research Institute

Phase 3 Completed
108 enrolled

High-grade Anal Intraepithelial Neoplasia

NCT02622568 2017-09-08

Investigating Veregen â„¢ 15% Ointment Treatment For Non-facial Verrucae in Pediatric Patients: A Pilot Study

University of Texas Southwestern Medical Center

Phase 4 Completed
28 enrolled 7 charts

Warts

NCT02029352 2016-05-18

Topical Green Tea Ointment in Treatment of Superficial Skin Cancer

Maastricht University Medical Center

Phase 2/3 Completed
42 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡